Browsing by Author Li, Liyun
Showing results 1 to 3 of 3
| Issue Date |
Title |
Author(s) |
| 15-Nov-2022 |
Preliminary Safety and Efficacy Results of EDI001: An Investigator Initiated Trial on CRISPR/Cas9-Modified Autologous CD34(+) Hematopoietic Stem and Progenitor Cells for Patients with Transfusion Dependent ss-Thalassemia |
Shi, Jun;Fang, Riguo;Gao, Zhen;Shi, Zhongyu;Kuang, Zhexiang;Zhang, Yongjian;Zhang, Lele;Yang, Huihui;Zhang, Yingchi;Zou, Dehui;Fang, Liwei;Sun, Jiali;Li, Qiang;Zou, Yao;Pan, Hong;Zhao, Jingyu;Li, Liyun;Yu, Xiao;Xu, Jing;Xu, Chun;Liu, Yanjie;Wang, Weiwei;Shi, Jia;Liu, Jie;Wang, Jia;Shi, Nian;Yang, Lei;Wang, Weiqiang;Li, Suyi;Shi, Moye;Zhang, Xiaoshuang;Yuan, Pengfei;Wei, Wensheng;Wei, Dong;Cheng, Tao |
| Jul-2021 |
RATIONALE 311: tislelizumab plus concurrent chemoradiotherapy for localized esophageal squamous cell carcinoma |
Yu, Rong;Wang, Wenqing;Li, Tao;Li, Jiancheng;Zhao, Kuaile;Wang, Weihu;Liang, Long;Wu, Haishan;Ai, Tashan;Huang, Wei;Li, Liyun;Yu, Wentao;Wei, Chenlu;Wang, Yidi;Shen, Wei;Xiao, Zefen |
| 10-Sep-2022 |
Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study |
Shen, Lin;Kato, Ken;Kim, Sung-Bae;Ajani, Jaffer A.;Zhao, Kuaile;He, Zhiyong;Yu, Xinmin;Shu, Yongqian;Luo, Qi;Wang, Jufeng;Chen, Zhendong;Niu, Zuoxing;Zhang, Longzhen;Yi, Tienan;Sun, Jong-Mu;Chen, Jianhua;Yu, Guohua;Lin, Chen-Yuan;Hara, Hiroki;Bi, Qing;Satoh, Taroh;Pazo-Cid, Roberto;Arkenau, Hendrick-Tobias;Borg, Christophe;Lordick, Florian;Li, Liyun;Ding, Ningning;Tao, Aiyang;Shi, Jingwen;Van Cutsem, Eric |
